| 0003-3734 |
OPDIVO |
nivolumab |
E.R. Squibb & Sons, L.L.C. |
INJECTION |
|
2017-12-08 |
| 0003-3756 |
OPDIVO |
nivolumab |
E.R. Squibb & Sons, L.L.C. |
INJECTION |
|
2021-08-30 |
| 0003-3772 |
OPDIVO |
nivolumab |
E.R. Squibb & Sons, L.L.C. |
INJECTION |
|
2014-12-22 |
| 0003-3774 |
OPDIVO |
nivolumab |
E.R. Squibb & Sons, L.L.C. |
INJECTION |
|
2014-12-22 |
| 0003-6120 |
OPDIVO QVANTIG |
nivolumab and hyaluronidase-nvhy |
E.R. Squibb & Sons, L.L.C. |
INJECTION, SOLUTION |
|
2025-01-02 |
| 0003-7125 |
OPDUALAG |
nivolumab and relatlimab-rmbw |
E.R. Squibb & Sons, L.L.C. |
INJECTION |
|
2022-03-18 |
| 0006-3026 |
KEYTRUDA |
pembrolizumab |
Merck Sharp & Dohme LLC |
INJECTION, SOLUTION |
|
2015-01-15 |
| 0006-3083 |
KEYTRUDA QLEX |
pembrolizumab and berahyaluronidase alfa-pmph |
Merck Sharp & Dohme LLC |
INJECTION, SOLUTION |
|
2025-09-19 |
| 0006-5083 |
KEYTRUDA QLEX |
pembrolizumab and berahyaluronidase alfa-pmph |
Merck Sharp & Dohme LLC |
INJECTION, SOLUTION |
|
2025-09-19 |
| 0173-0898 |
Jemperli |
dostarlimab |
GlaxoSmithKline LLC |
INJECTION |
|
2021-04-22 |
| 50242-917 |
TECENTRIQ |
atezolizumab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2016-05-18 |
| 50242-918 |
TECENTRIQ |
atezolizumab |
Genentech, Inc. |
INJECTION, SOLUTION |
|
2019-03-08 |
| 50242-933 |
Tecentriq Hybreza |
atezolizumab and hyaluronidase-tqjs |
Genentech, Inc. |
INJECTION |
|
2024-09-12 |
| 50881-006 |
ZYNYZ |
retifanlimab-dlwr |
Incyte Corporation |
INJECTION |
|
2023-03-22 |
| 70114-340 |
LOQTORZI |
toripalimab-tpzi |
Coherus BioSciences, Inc. |
INJECTION |
|
2023-10-27 |
| 72579-121 |
TEVIMBRA |
tislelizumab-jsgr |
BeOne Medicines USA, Inc. |
INJECTION, SOLUTION, CONCENTRATE |
|
2024-03-14 |